title: Toxoplasmosis in kidney transplant recipients: a life-threatening but treatable disease.
authors.affiliation: Service de Néphrologie, Centre Hospitalier et Régional de Nancy, France.
authors.forename: E
authors.initials: E
authors.lastname: Renoult
authors.forename: E
authors.initials: E
authors.lastname: Georges
authors.forename: M F
authors.initials: MF
authors.lastname: Biava
authors.forename: C
authors.initials: C
authors.lastname: Hulin
authors.forename: L
authors.initials: L
authors.lastname: Frimat
authors.forename: D
authors.initials: D
authors.lastname: Hestin
authors.forename: M
authors.initials: M
authors.lastname: Kessler
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001344:Autopsy; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000890:Anti-Infective Agents; D013411:Sulfadiazine; D002981:Clindamycin; D011739:Pyrimethamine